When you first enter medical school, it can be difficult to envision yourself having the confidence and knowledge […]
The free event will discuss key insights into achieving impactful patient partnerships and advocacy
The approval broadens the drug’s label to include fifth treatment option in the relapsed/refractory multiple myeloma setting
The move will expand Janssen’s presence in autoimmune diseases
Trusts should aim to recruit at least 60% of eligible COVID-19 patients into trials
The treatment, developed by UCL clinicians, allows for surgery and radiation therapy at the same time
Updated Date: Thu, 13 Aug 2020 00:00:00 EDT
Novartis gets a green light to challenge Roche, Sanofi with delayed MS med Kesimpta chelfand Thu, 08/20/2020 – […]
The government has announced that it will lift the cap on the number of medical school places in […]
